Durham, North Carolina-based IQVIA Holdings Inc. (IQV) is a leading global provider of clinical research services, healthcare intelligence, advanced analytics, and technology solutions for the life sciences and healthcare industries. Valued at $41 billion by market cap, the company helps pharmaceutical, biotechnology, and medical-device companies develop, test, and commercialize new treatments by combining vast healthcare data with AI, analytics, and deep industry expertise.
IQVIA has given investors a reason to cheer, outpacing the broader market over the past year. IQV has surged 33.3% over this time frame, outpacing the S&P 500 Index ($SPX) has rallied nearly 19.5% and the Health Care Select Sector SPDR Fund’s (XLV) 25.4% return.